IL18 and neoplasm: Co-expression of GzB-IL18 with pCAR-H/T promoted a significant (MDA-MB-468) or a trend (BxPC3) toward an increased number of stimulation cycles in which ≥60% of tumor was destroyed (Figure S6A).